Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Wino115

T.TH

RE:RE:THTX start commenting

This is the month they'll get their first chance to talk. The path to...

February 1, 2023

T.TH

RE:Preclinical results

There's a few others looking at different approaches that have gotten...

January 29, 2023

T.TH

RE:RE:RE:TH1902 ClinicalTrials.gov Update

One looks like a fairly standard CRO but some of the others seem to have no...

January 28, 2023

T.TH

RE:RE:RE:RE:RE:New asset opportunities

Given developments, I'm fine with having all senior managers aligned to...

January 27, 2023

T.TH

RE:Bargain hunters

While we are all stilted and jaded shareholders, for someone new it's not...

January 25, 2023

T.TH

RE:FDA accepted Intercept’s NDA for NASH!

Any news validating any portions of the overall NASH therapeutic market as...

January 23, 2023

T.TH

RE:RE:They act like big pharma. That's a problem

As they have stated in the new Presentation, there is both a financial plan...

January 19, 2023

T.TH

RE:Pfizer

Part of the process they need to get through with whatever data they have on...

January 18, 2023

T.TH

RE:RE:Article from Bloomberg of note

Would make sense just to partner on rights for that indication and carve it...

January 17, 2023

T.TH

RE:RE:RE:RE:RE:RE:RE:Hey THERA executives...any value??

Yep, I'd agree with you on this and I guess I'm not slamming them as...

January 11, 2023

T.TH

RE:RE:RE:RE:RE:Hey THERA executives...any value??

Link if you want to read it:  They are recruiting still right now and...

January 11, 2023

T.TH

RE:RE:RE:RE:Hey THERA executives...any value??

Guarantee you they have read it and spoken to MD Anderson on it, maybe even...

January 11, 2023

T.TH

RE:RE:Hey THERA executives...any value??

I forgot to point out that you can just search Clinicaltrials.gov for CBX-12...

January 11, 2023

T.TH

RE:Hey THERA executives...any value??

On that staining sample poster they presented, Prostate was one where there...

January 11, 2023

T.TH

RE:RE:It seems like..

Now that would be a nice sales partner. Get that combo drug plan going THTX. ...

January 10, 2023

T.TH

RE:RE:RE:RE:Presentation is a good sign

I wouldn't take the employee count as something that would get...

January 10, 2023

T.TH

RE:New presentation up - realistic review.

Sorry - here's image:   [img]https://ibb.co/Tkbm6md">

January 8, 2023

T.TH

New presentation up - realistic review.

Basically sums up the letter, but adds a few more points around HIV drug...

January 8, 2023

T.TH

RE:RE:Next 5 months

An interesting development would be if they can license in some mid-size...

January 7, 2023

T.TH

RE:RE:Therapeutic window

To increase probabilities, they need to at least have data-based theories on...

January 6, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

BioVaxys Technology Corp.

BioVaxys Technology Corp. C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ... view more »